Pharmascience in Brief
Founded in 1983, Pharmascience Inc. is the largest pharmaceutical employer in Quebec with over 1500 employees proudly headquartered in Montreal. Pharmascience Inc. is a full-service privately owned pharmaceutical company with strong roots in Canada and a growing global reach with product distribution in over 60 countries. Ranked 57th among Canada’s top 100 R&D investors with over $44 million invested in 2015, Pharmascience Inc. is the 10th largest pharmaceutical company in Canada. Pharmascience Inc. has strong long-standing philanthropic ties with its communities, both locally and internationally. For more than 20 years, Pharmascience has been working through Health Partners International of Canada (HPIC) as the partner of choice to increase access to medicine. Pharmascience’s total donations of essential medicine, is close to $60 million. Pharmascience Inc. is a leading manufacturer and marketer of prescription; generic, over-the-counter, and behind-the-counter products as well as FDA approved Canadian-made injectables. Pharmascience Inc. commercializes nearly 400 product families in 20 different dosage forms for over 2,000 products. In Canada alone, more than 45 million prescriptions a year are filled with Pharmascience products.
Pharmascience Quick Facts
1.Co-founded by pharmacists Morris Goodman and Ted Wise in 1983;
2.Largest pharmaceutical employer in Quebec, Canada, with 1,500 employees;
3.Third largest generic pharmaceutical company in Canada and third largest pharmaceutical company in Canada by number of prescriptions;
4.Ranked 57th among Canada's top 100 R&D investors with CAD $44 million invested annually;
5.Diversified portfolio of over 400 product families, both prescription and OTC;
6.Sales in more than 60 countries;
7.One of the largest providers of generic single-source products;
8.A leader in customer service & support.
Chairman of the Board
As one of Canada's leading entrepreneurs and a pioneer in the generic drug industry, Mr. Goodman has dedicated his career to "Creating the Difference" in healthcare in Canada and worldwide. He graduated from the Faculty of Pharmacy at the University of Montreal in 1953 at the young age of twenty-one.
After graduation, Mr. Goodman focused on the industry side of pharmacy and quickly obtained distribution rights from several international pharmaceutical companies to bring their products to the Canadian marketplace. He marketed and sold these products in Canada under the company name of Winley-Morris Co. Ltd.
In 1971, Mr. Goodman approached a California-based company, International Chemical & Nuclear Corporation (ICN) and became their Canadian distributor of L-Dopa. Impressed with his innovative approach, they purchased Winley-Morris and established Morris Goodman as President of ICN Canada.
In 1983, Mr. Goodman co-founded Pharmascience Inc. with his good friend and colleague, Ted Wise. As Co-Founder & Chairman of the Board of Pharmascience Inc., Morris Goodman has been at the forefront of the company's explosive growth and development, leading it to its current standing as one of the top three generic pharmaceutical companies in Canada.
Notwithstanding his business successes, Mr. Goodman is a leader in philanthropic initiatives. Included among the major charitable donations made by The Morris & Rosalind Goodman Family Foundation are The Stroke Unit at the Jewish General Hospital, the Agora at the Faculty of Pharmacy at the University of Montreal and The Goodman Cancer Research Centre at McGill University.
In May of 2011, McGill University bestowed an honorary degree upon Mr. Goodman.
Chief Executive Officer
Dr. David Goodman is Chief Executive Officer of Pharmascience, which is today the 2nd largest privately-owned pharmaceutical company in Canada.
Dr. Goodman obtained his Bachelor degree in Commerce from McGill University, and his Ph.D. in pharmacology from the University of Virginia. Upon graduation, he began his career at Pharmascience in Business Development and has gained significant experience in progressively senior international and domestic roles.
Under Dr. Goodman's leadership, Pharmascience has gone from being a strictly Canadian company to becoming an important player on the global stage. Pharmascience strives to be the first company to launch its generic pipeline in Canada, Europe and various markets throughout the world.
Dr. Goodman's success is his belief and insistence on major and constant investment in internal and external R&D programs, as well as in employee development.
Chief Operating Officer
As Chief Operating Officer, Larry brings a dynamic, personable leadership style to Pharmascience Inc. Larry is responsible for the commercial operations strategic oversight of Pharmascience, inspiring out of the box thinking throughout the company.
During his 17 years at Ciba Vision Corp., a Novartis company, Larry rose to Vice President Sales-North American Lens Business before being promoted to General Manager-Canada. Throughout his career, Larry has been a keen advocate of fostering strong relationships, connecting with clients and business partners alike, generating profound insights that benefit their business in unexpected ways.
Larry holds a Bachelor degree in Business Administration from York University, and has also participated in executive-focused programs at Harvard Northwestern and Cornell. He currently holds the position of Chair of the Canadian Generic Pharmaceutical Association (CGPA). He is continually seeking new ideas that will bring unique value to our customers and ensure Pharmascience's continued success.